Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
03 Jun 2024
Historique:
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: aheadofprint

Résumé

Elevated values of high-sensitivity cardiac troponin (hs-cTn) are common in patients with acute ischemic stroke and are associated with poor prognosis. However, diagnostic and therapeutic implications in patients with ischemic stroke remain unclear. To identify factors indicative of myocardial infarction (MI) in patients with acute ischemic stroke and hs-cTn elevation. The primary hypothesis was that a dynamic change of hs-cTn values (>50% change) in patients with acute ischemic stroke indicates MI. This cross-sectional study was a prospective, observational study with blinded end-point assessment conducted across 26 sites in Germany. Patients were included if they had acute ischemic stroke within 72 hours and either (1) highly elevated hs-cTn values on admission (>52 ng/L) or (2) hs-cTn levels above the upper limit of normal and a greater than 20% change at repeated measurements. Patients were enrolled between August 2018 and October 2020 and had 1 year of follow-up. Statistical analysis was performed between April 2022 and August 2023. Standardized electrocardiography, echocardiography, and coronary angiography. Diagnosis of MI as adjudicated by an independent end-point committee based on the findings of electrocardiography, echocardiography, and coronary angiography. In total, 254 patients were included. End points were adjudicated in 247 patients (median [IQR] age, 75 [66-82] years; 117 were female [47%] and 130 male [53%]). MI was present in 126 of 247 patients (51%) and classified as type 1 MI in 50 patients (20%). Dynamic change in hs-cTn value was not associated with MI in univariable (32% vs 38%; χ2 P = .30) or adjusted comparison (odds ratio, 1.05; 95% CI, 0.31-3.33). The baseline absolute hs-cTn value was independently associated with type 1 MI. The best cutoffs for predicting type 1 MI were at hs-cTn values 5 to 10 times the upper limit normal. This study found that in patients with acute ischemic stroke, a dynamic change in hs-cTn values did not identify MI, underscoring that dynamic changes do not identify the underlying pathophysiological mechanism. In exploratory analyses, very high absolute hs-cTn values were associated with a diagnosis of type 1 MI. Further studies are needed how to best identify patients with stroke who should undergo coronary angiography.

Identifiants

pubmed: 38829625
pii: 2819394
doi: 10.1001/jamaneurol.2024.1552
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Christian H Nolte (CH)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.
Berlin Institute of Health (BiH), Berlin, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Berlin, Germany.

Regina von Rennenberg (R)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE) Partner Site, Berlin, Germany.

Simon Litmeier (S)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE) Partner Site, Berlin, Germany.

David M Leistner (DM)

Department of Cardiology, Goethe University Frankfurt, Frankfurt am Main, Germany.

Kristina Szabo (K)

Department of Neurology, Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Department of Neurology, Mannheim, Germany.

Stefan Baumann (S)

First Department of Medicine-Cardiology, University Medical Centre Mannheim and DZHK (German Centre for Cardiovascular Research) Partner Site, Heidelberg/Mannheim, Germany.

Annerose Mengel (A)

Department of Neurology and Stroke, University Tübingen, Tübingen, Germany.

Dominik Michalski (D)

Department of Neurology, University Leipzig, Leipzig, Germany.

Timo Siepmann (T)

Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Stephan Blankenberg (S)

Department of Cardiology, University Heart & Vascular Center Hamburg, Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Hamburg, Hamburg, Germany.

Gabor C Petzold (GC)

Section of Vascular Neurology, Department for Neurology, Universitätsklinikum Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE) Partner Site, Bonn, Germany.

Martin Dichgans (M)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE) Partner Site, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Munich, Germany.

Hugo Katus (H)

Department for Cardiology, Angiology, Pneumology, Universitätsklinikum Heidelberg, Heidelberg, Germany.

Burkert Pieske (B)

Department of Cardiology, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Vera Regitz-Zagrosek (V)

Institute of Gender in Medicine (GiM), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Tim Bastian Braemswig (TB)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.
Berlin Institute of Health (BiH), Berlin, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Berlin, Germany.

Ida Rangus (I)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.

Amra Pepic (A)

Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Eik Vettorazzi (E)

Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Andreas M Zeiher (AM)

Department for Cardiology, Goethe University Frankfurt, Frankfurt am Main, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Frankfurt, Germany.

Jan F Scheitz (JF)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.
Berlin Institute of Health (BiH), Berlin, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Berlin, Germany.

Karl Wegscheider (K)

German Centre for Cardiovascular Research (DZHK) Partner Site, Hamburg, Hamburg, Germany.
Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ulf Landmesser (U)

German Centre for Cardiovascular Research (DZHK) Partner Site, Berlin, Germany.
Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Matthias Endres (M)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin (CSB), Berlin, Germany.
Berlin Institute of Health (BiH), Berlin, Germany.
German Centre for Cardiovascular Research (DZHK) Partner Site, Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE) Partner Site, Berlin, Germany.
Excellence Cluster NeuroCure, Berlin, Germany.

Classifications MeSH